Alpha Cubed Investments’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,579
Closed -$243K 281
2023
Q1
$243K Buy
1,579
+332
+27% +$54.8K 0.02% 224
2022
Q4
$224K Buy
+1,247
New +$204K 0.02% 245
2022
Q3
Sell
-1,485
Closed -$212K 302
2022
Q2
$212K Sell
1,485
-560
-27% -$80K 0.02% 281
2022
Q1
$352K Buy
+2,045
New +$344K 0.02% 234
2021
Q1
Sell
-2,311
Closed -$241K 271
2020
Q4
$241K Buy
+2,311
New +$234K 0.02% 218

Other funds holding MRNA

Alpha Cubed Investments's MRNA Position: Q2 2023 in Review

Alpha Cubed Investments sold out of Moderna (MRNA) in Q2 2023, closing a stake of 1,579 shares — an estimated $243K sold.

Alpha Cubed Investments first reported a position in MRNA in Q4 2020 and held it in 5 quarters. The position peaked at $352K in Q1 2022. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Alpha Cubed Investments reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Alpha Cubed Investments sold 1,579 Moderna shares in Q2 2023, an estimated $243K.
  • Alpha Cubed Investments first reported a position in Moderna in Q4 2020 and held it in 5 quarters.
  • Alpha Cubed Investments's Moderna position peaked at $352K in Q1 2022.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Alpha Cubed Investments's 13F filing for Q2 2023, filed 20 Jul 2023.